In the media
News
In the media
BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs
Read full storyIn the media
As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on
Read full storyIn the media